New4med GmbH Announces First Cases of its novel Basivertebral Nerve Ablation (BVNA)

Published on July 8, 2024

LADENBURG, Germany, July 8, 2024 /PRNewswire/ — New4med GmbH, a German startup focused on innovative spinal treatments, announces the successful European market launch of its novel Basivertebral Nerve Ablation (BVNA) therapy. BVNA is a treatment for vertebrogenic pain, a type of chronic low back pain associated with bony lesions on the vertebral endplates. The system, approved in Europe, is a …

The post New4med GmbH Announces First Cases of its novel Basivertebral Nerve Ablation (BVNA) appeared first on Ortho Spine News.